Yiming Li
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
- Immunology 17
- Immune Cell Function and Interaction 4
-
- HIV/AIDS drug development and treatment 4
- Co-authors
- Zhiyong Peng (15 shared papers)Yanbing Ding (2 shared papers)Yanjun Zhong (3 shared papers)Junke Long (3 shared papers)Xia Wu (1 shared paper)Chang Hu (8 shared papers)Bingqing Wang (2 shared papers)Yue Wang (1 shared paper)
- Journals
- Frontiers in Immunology (3 papers)PLoS ONE (3 papers)Physical Review Letters (2 papers)Critical Care (2 papers)International Immunopharmacology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yiming Li
77 papers receiving 3.3k citations
Yiming Li's Hit Papers
Peers
Comparison fields: 5 of 166
- Infectious Diseases 888
- Neurology 410
- Critical Care and Intensive Care Medicine 97
- Nutrition and Dietetics 273
- Nephrology 121
Countries citing papers authored by Yiming Li
This map shows the geographic impact of Yiming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiming Li more than expected).
Fields of papers citing papers by Yiming Li
This network shows the impact of papers produced by Yiming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiming Li. The network helps show where Yiming Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Yiming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The epidemiology, diagnosis and treatment of COVID-19 Hit paper breakdown → | 2020 | 680 |
| 2 | ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis Hit paper breakdown → | 2023 | 554 |
| 3 | 2020 | 314 | |
| 4 | Pilot trial of high-dose vitamin C in critically ill COVID-19 patients Hit paper breakdown → | 2021 | 193 |
| 5 | 2020 | 190 | |
| 6 | 2020 | 116 | |
| 7 | 2016 | 88 | |
| 8 | 2014 | 83 | |
| 9 | 2020 | 76 | |
| 10 | 2022 | 70 | |
| 11 | 2020 | 57 | |
| 12 | 2018 | 51 | |
| 13 | 1998 | 43 | |
| 14 | 2020 | 42 | |
| 15 | 2020 | 41 | |
| 16 | 2015 | 40 | |
| 17 | 2023 | 40 | |
| 18 | 2021 | 37 | |
| 19 | 2022 | 37 | |
| 20 | 2020 | 36 |
About Yiming Li
Yiming Li is a scholar working on Immunology, Infectious Diseases, Nephrology, Neurology and Epidemiology, having authored 82 papers that have together received 3.4k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (6 papers), Acute Kidney Injury Research (6 papers), Inflammasome and immune disorders (5 papers), Immune Cell Function and Interaction (4 papers), HIV/AIDS drug development and treatment (4 papers), Chronic Kidney Disease and Diabetes (4 papers), Neonatal Respiratory Health Research (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). The work is most often cited by research in Infectious Diseases (888 citations), Neurology (410 citations), Critical Care and Intensive Care Medicine (97 citations), Nutrition and Dietetics (273 citations) and Nephrology (121 citations). Yiming Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhiyong Peng, Yanbing Ding, Yanjun Zhong, Junke Long, Xia Wu, Chang Hu, Bingqing Wang, Yue Wang, Jun Jiang and Jing Zhang. Their work appears in journals such as Frontiers in Immunology, PLoS ONE, Physical Review Letters, Critical Care and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.